Trial Profile
Combined treatment of apatinib with radiotherapy in primary hepatocellular carcinoma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Jul 2017
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 11 Jul 2017 New trial record